About Antares Pharma
On May 24th, 2022, Antares Pharma was acquired by Halozyme Therapeutics. Antares Pharma is a specialized pharmaceutical firm primarily dedicated to the development and marketing of pharmaceutical medicines and technology that answer patient requirements in certain therapeutic areas. The company was founded in 1979 and is based in Ewing, NJ.
Antares Pharma Patents
Antares Pharma has filed 118 patents.
Sedatives, Drug delivery devices, Barbiturates, Fluoroarenes, Hypnotics
Sedatives, Drug delivery devices, Barbiturates, Fluoroarenes, Hypnotics
Latest Antares Pharma News
Nov 6, 2023
Auto Injectors Market Industry Share, Size, Growth, Demands, Revenue, Top Leaders and Forecast Countless efforts of analysts, researchers and industry experts have been put forth to structure an excellent Global Auto Injectors Market business report. As quality is an essential aspect and the soul of the business, this report has also been provided with an utmost quality. This report assists to design capital investment strategies based on forecasted high potential segments. Moreover, to plan for a new product launch and inventory in advance, this report provides several useful insights. The winning Global Auto Injectors Market report also includes detailed profiles of market’s major manufacturers and importers who are dominating the market. The large scale Auto Injectors Market report conducts analysis on consumption of market, key players involved, sales, price, revenue and market share with volume and value for each region. This industry analysis report has been prepared with a nice blend of industry insight, smart and practical solutions and newest technology to present better user experience. This global market document also encompasses predictions utilizing a practical arrangement of uncertainties and techniques. Auto Injectors Market analysis report comprises of better market insights with which driving the business into right direction becomes easy. In addition, it makes out and analyses the emerging trends along with major driving factors, challenges and opportunities in the market for HEALTHCARE industry. Auto injectors are utilized for epinephrine self-administration in order to prevent anaphylaxis, for immediate pain relief by migraine sufferers and for medical and emergency treatments. The rise in incidence of anaphylaxis is escalating the growth of auto injectors market. The auto injectors market was valued at USD 56.01 billion in 2021 and is expected to reach USD 270.78 billion by 2029, registering a CAGR of 21.77% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. An auto injector refers to a syringe with a spring-charged needle that has a pre-charged dosage of drugs. A measured dosage of a drug is triggered and administered when pressed into the body with a sliding motion. Auto-injectors offer various advantages such as, reducing needle-related phobia disorder , and risks of needle stuck accidents, among others. Restraints/Challenges Global Auto Injectors Market On the other hand, increase in the preference for alternative drug delivery modes and development of nasal epinephrine sprays are expected to obstruct market growth. Also, development of autoinjectors for multiple drug viscosities and lack of proper training for using auto injectors are projected to challenge the auto injectors market in the forecast period of 2022-2029. This auto injectors market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on auto injectors market contact Data Bridge Market Research for an Analyst Brief , our team will help you take an informed market decision to achieve market growth. Recent Development Antares Pharma (US) made an agreement with Lunatus Global Medical Supplies (Dubai) in August’2020. Antares is expected to supply packaged products to Lunatus according to the agreement. Lunatus will submit and obtain regulatory approval for XYOSTED in the UAE and Saudi Arabia, and will promote, market and distribute XYOSTED in these two countries. Browse Complete Report Details- https://www.databridgemarketresearch.com/reports/global-auto-injectors-market?Shri Auto Injectors Market Scope and Market Size The auto injectors market is segmented on the basis of therapy, type, end- users, route of administration, molecule, design and product. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications. Therapy The report provides insights on the following pointers: Market Penetration: Comprehensive information on the product portfolios of the top players in the this market Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the market Competitive Assessment: In-depth assessment of the market strategies, and geographic and business segments of the leading players in the market Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies Critical Insights Related to This Market Included in the Report: Exclusive graphics and Illustrative SWOT analysis of some of the leading companies in this market Value chain analysis of prominent players in the market Current trends influencing the dynamics of this market across various geographies Recent mergers, acquisitions, collaborations, and partnerships Revenue growth of this industry over the forecast period Marketing strategy study and growth trends Growth driven factor analysis An empirical evaluation of the curve of this market Ancient, Present, and Probable scope of the market from both prospect value and volume Some of the major players operating in the auto injector market are AbbVie Inc. (US), Mylan N.V. (US), Lily. (US), Amgen Inc. (US), Ypsomed Holding (Switzerland), BD (US), Owen Mumford Ltd. (UK), Consort Medical, Plc. (UK), SHL Medical AG (Switzerland), Johnson Medtech, LLC. (US), Teva Pharmaceuticals USA, Inc. (US), Antares Pharma. (New Jersey), AstraZeneca (UK), Union Medico Inc. (Denmark), Gerresheimer AG (Germany), West Pharmaceutical Services, Inc (US), and Emergent. (US), among others. Key Advantages of the Report: This study provides an analytical overview of the industry, including current trends and future predictions to identify potential investment opportunities. The report offers insights into key drivers, limitations, and prospects, along with a comprehensive market share analysis. The report quantitatively assesses the current market, shedding light on its growth prospects. A Porter’s five forces analysis gauges the bargaining power of buyers and suppliers in the market. The report delivers an in-depth market analysis that considers competitive dynamics and forecasts the future competitive landscape. What to Anticipate from the Report – A 7-Point Guide: The report delves into the holistic strategy and innovation within the market ecosystem. It highlights prominent market drivers and obstacles, providing clarity on technological standardization and regulatory frameworks. The report evaluates various implementation models and examines numerous use cases. Serving as a valuable resource, the report offers essential industry insights, showcasing information on new investments, stakeholders, relevant contributors, and market participants. Through the forecast period, the report conducts a thorough market analysis, referencing historical developments, ongoing events, and future growth prospects. Top DBMR Healthcare Reports: An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate. Contact Us:-
Antares Pharma Frequently Asked Questions (FAQ)
When was Antares Pharma founded?
Antares Pharma was founded in 1979.
Where is Antares Pharma's headquarters?
Antares Pharma's headquarters is located at 250 Phillips Boulevard, Ewing.
What is Antares Pharma's latest funding round?
Antares Pharma's latest funding round is Acq - P2P.
How much did Antares Pharma raise?
Antares Pharma raised a total of $6.2M.
Who are the investors of Antares Pharma?
Investors of Antares Pharma include Halozyme Therapeutics, HSBC, MMV Financial, Hudson Bay Capital Management, Perceptive Advisors and 46 more.
Who are Antares Pharma's competitors?
Competitors of Antares Pharma include Love Lifesciences.
Compare Antares Pharma to Competitors
Owen Mumford designs and manufactures medical devices. The company offers devices for venepuncture, eye care, neuropathy, diabetes care, and more. It was founded in 1952 and is based in Oxfordshire, United Kingdom.
Ypsomed develops and manufactures injection and infusion systems for self-medication. The company's product mylife Diabetescare offers a therapy management solution designed for people with diabetes for self-medication. It was founded in 2003 and is based in Burgdorf, Switzerland.
Love Lifesciences develops a series of injection safety devices that improves the patient experience when injection medications are required for care. It provides patients with injection control while limiting the opportunity for error. The company was founded in 2021 and is based in Overland Park, Kansas.
Becton Dickinson (NYSE: BDX) operates as a medical technology company. It manufactures and sells a broad range of supplies, devices, and systems for use by healthcare professionals, medical research institutions, industry, and the general public. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.